Does combined hormone replacement therapy improve the health-related quality of life of postmenopausal women?

Nature Clinical Practice Endocrinology and Metabolism

Volumn 5, Issue 3, 2009, Pages 136-137

  Nachtigall, Lila ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Health related quality of life; Hormone replacement therapy; Postmenopausal symptoms

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE;

ADULT; AGED; BREAST TENDERNESS; FEMALE; HORMONE SUBSTITUTION; HUMAN; MENOPAUSAL SYNDROME; NOTE; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; SEXUAL FUNCTION; TREATMENT RESPONSE; VAGINA DISCHARGE;

EID: 60749109867     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet1079     Document Type: Note

References (5)

1. Utian WH (2008) Estrogen and progestogen use in postmenopausal women: July 2008 position statement of the North American Menopause Society. Menopause 15: 584-602
2. Hays J et al. (2003) Effects of estrogen plus progestin on health related quality of life. N Engl J Med 348: 1839-1854
3. Rossouw JE et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333
4. Hlatky MA et al. (2002) Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. JAMA 287: 591-597
5. Welton AJ et al. (2008) Health related quality of life after combined hormone replacement therapy: randomized controlled trial. BMJ 337: a1190